Onconetix, Inc. Amends Share Exchange Agreement with Realbotix

Onconetix, Inc. has entered into a First Amendment to its Share Exchange Agreement with Realbotix Corp., Simulacra Corporation, and Realbotix, LLC. Key changes include a revised ownership structure if Net Cash falls below $12.5 million, where the Seller would own 95% of Onconetix's fully diluted shares. The definition of Net Cash has been expanded to include outstanding balances on a specific Grid Promissory Note. Additionally, the closing deadline (End Date) for the transaction has been extended to March 31, 2027.